vs
豪洛捷（HOLX）与越洋钻探（RIG）财务数据对比。点击上方公司名可切换其他公司
豪洛捷的季度营收约是越洋钻探的1.0倍（$1.0B vs $1.0B），豪洛捷净利率更高（17.1% vs 2.4%，领先14.7%），越洋钻探同比增速更快（9.6% vs 2.5%），越洋钻探自由现金流更多（$321.0M vs $215.2M），过去两年越洋钻探的营收复合增速更高（16.9% vs 1.5%）
豪洛捷是一家总部位于美国的医疗科技企业，核心业务聚焦女性健康领域，旗下产品涵盖诊断、外科手术及医学影像类专业医疗设备，为全球各地的医疗场景提供优质技术与产品支持。
越洋钻探（Transocean Ltd.）是按营收计全球规模最大的海上钻探承包商，总部位于瑞士施泰因豪森，起源于美国，目前在加拿大、美国、挪威、英国、印度、巴西、新加坡等20个国家设有办事机构，业务覆盖全球主要海上油气开采区域。
HOLX vs RIG — 直观对比
营收规模更大
HOLX
是对方的1.0倍
$1.0B
营收增速更快
RIG
高出7.0%
2.5%
净利率更高
HOLX
高出14.7%
2.4%
自由现金流更多
RIG
多$105.8M
$215.2M
两年增速更快
RIG
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.0B |
| 净利润 | $179.1M | $25.0M |
| 毛利率 | 56.0% | 42.0% |
| 营业利润率 | 22.6% | 23.0% |
| 净利率 | 17.1% | 2.4% |
| 营收同比 | 2.5% | 9.6% |
| 净利润同比 | -10.9% | 257.1% |
| 每股收益（稀释后） | $0.79 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOLXRIG
| Q4 25 | $1.0B | $1.0B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.0B | $988.0M | ||
| Q1 25 | $1.0B | $906.0M | ||
| Q4 24 | $1.0B | $952.0M | ||
| Q3 24 | $988.0M | $948.0M | ||
| Q2 24 | $1.0B | $861.0M | ||
| Q1 24 | $1.0B | $763.0M |
净利润HOLXRIG
| Q4 25 | $179.1M | $25.0M | ||
| Q3 25 | $187.2M | $-1.9B | ||
| Q2 25 | $194.9M | $-938.0M | ||
| Q1 25 | $-17.4M | $-79.0M | ||
| Q4 24 | $201.0M | $7.0M | ||
| Q3 24 | $178.6M | $-494.0M | ||
| Q2 24 | $194.5M | $-123.0M | ||
| Q1 24 | $169.9M | $98.0M |
毛利率HOLXRIG
| Q4 25 | 56.0% | 42.0% | ||
| Q3 25 | 55.6% | 43.2% | ||
| Q2 25 | 56.3% | 39.4% | ||
| Q1 25 | 37.5% | 31.8% | ||
| Q4 24 | 56.8% | 39.2% | ||
| Q3 24 | 56.4% | 40.6% | ||
| Q2 24 | 55.4% | 38.0% | ||
| Q1 24 | 53.3% | 31.5% |
营业利润率HOLXRIG
| Q4 25 | 22.6% | 23.0% | ||
| Q3 25 | 22.6% | -163.1% | ||
| Q2 25 | 24.9% | -97.6% | ||
| Q1 25 | -0.7% | 7.1% | ||
| Q4 24 | 22.5% | 13.7% | ||
| Q3 24 | 23.3% | -51.2% | ||
| Q2 24 | 24.1% | -6.9% | ||
| Q1 24 | 20.7% | -0.4% |
净利率HOLXRIG
| Q4 25 | 17.1% | 2.4% | ||
| Q3 25 | 17.8% | -187.1% | ||
| Q2 25 | 19.0% | -94.9% | ||
| Q1 25 | -1.7% | -8.7% | ||
| Q4 24 | 19.7% | 0.7% | ||
| Q3 24 | 18.1% | -52.1% | ||
| Q2 24 | 19.2% | -14.3% | ||
| Q1 24 | 16.7% | 12.8% |
每股收益（稀释后）HOLXRIG
| Q4 25 | $0.79 | $0.13 | ||
| Q3 25 | $0.84 | $-2.00 | ||
| Q2 25 | $0.86 | $-1.06 | ||
| Q1 25 | $-0.08 | $-0.11 | ||
| Q4 24 | $0.87 | $-0.14 | ||
| Q3 24 | $0.75 | $-0.58 | ||
| Q2 24 | $0.82 | $-0.15 | ||
| Q1 24 | $0.72 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $620.0M |
| 总债务越低越好 | $2.5B | $5.2B |
| 股东权益账面价值 | $5.2B | $8.1B |
| 总资产 | $9.2B | $15.6B |
| 负债/权益比越低杠杆越低 | 0.48× | 0.64× |
8季度趋势，按日历期对齐
现金及短期投资HOLXRIG
| Q4 25 | $2.4B | $620.0M | ||
| Q3 25 | $2.2B | $833.0M | ||
| Q2 25 | $1.9B | $377.0M | ||
| Q1 25 | $1.6B | $263.0M | ||
| Q4 24 | $2.0B | $560.0M | ||
| Q3 24 | $2.3B | $435.0M | ||
| Q2 24 | $2.4B | $475.0M | ||
| Q1 24 | $2.2B | $446.0M |
总债务HOLXRIG
| Q4 25 | $2.5B | $5.2B | ||
| Q3 25 | $2.5B | $4.8B | ||
| Q2 25 | $2.5B | $5.9B | ||
| Q1 25 | $2.5B | $5.9B | ||
| Q4 24 | $2.5B | $6.2B | ||
| Q3 24 | $2.5B | $6.5B | ||
| Q2 24 | $2.5B | $6.8B | ||
| Q1 24 | $2.6B | $6.8B |
股东权益HOLXRIG
| Q4 25 | $5.2B | $8.1B | ||
| Q3 25 | $5.0B | $8.1B | ||
| Q2 25 | $4.8B | $9.4B | ||
| Q1 25 | $4.6B | $10.2B | ||
| Q4 24 | $4.8B | $10.3B | ||
| Q3 24 | $5.1B | $10.2B | ||
| Q2 24 | $5.0B | $10.7B | ||
| Q1 24 | $4.8B | $10.5B |
总资产HOLXRIG
| Q4 25 | $9.2B | $15.6B | ||
| Q3 25 | $9.0B | $16.2B | ||
| Q2 25 | $8.8B | $17.8B | ||
| Q1 25 | $8.5B | $19.0B | ||
| Q4 24 | $8.7B | $19.4B | ||
| Q3 24 | $9.2B | $19.5B | ||
| Q2 24 | $8.9B | $20.3B | ||
| Q1 24 | $8.7B | $19.9B |
负债/权益比HOLXRIG
| Q4 25 | 0.48× | 0.64× | ||
| Q3 25 | 0.50× | 0.60× | ||
| Q2 25 | 0.52× | 0.63× | ||
| Q1 25 | 0.55× | 0.58× | ||
| Q4 24 | 0.53× | 0.60× | ||
| Q3 24 | 0.49× | 0.64× | ||
| Q2 24 | 0.51× | 0.63× | ||
| Q1 24 | 0.53× | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.9M | $349.0M |
| 自由现金流经营现金流 - 资本支出 | $215.2M | $321.0M |
| 自由现金流率自由现金流/营收 | 20.5% | 30.8% |
| 资本支出强度资本支出/营收 | 1.4% | 2.7% |
| 现金转化率经营现金流/净利润 | 1.28× | 13.96× |
| 过去12个月自由现金流最近4个季度 | $1.0B | $626.0M |
8季度趋势，按日历期对齐
经营现金流HOLXRIG
| Q4 25 | $229.9M | $349.0M | ||
| Q3 25 | $355.1M | $246.0M | ||
| Q2 25 | $343.3M | $128.0M | ||
| Q1 25 | $169.4M | $26.0M | ||
| Q4 24 | $189.3M | $206.0M | ||
| Q3 24 | $367.0M | $194.0M | ||
| Q2 24 | $405.8M | $133.0M | ||
| Q1 24 | $292.4M | $-86.0M |
自由现金流HOLXRIG
| Q4 25 | $215.2M | $321.0M | ||
| Q3 25 | $341.4M | $235.0M | ||
| Q2 25 | $330.5M | $104.0M | ||
| Q1 25 | $153.9M | $-34.0M | ||
| Q4 24 | $172.5M | $177.0M | ||
| Q3 24 | $350.6M | $136.0M | ||
| Q2 24 | $385.3M | $49.0M | ||
| Q1 24 | $279.6M | $-169.0M |
自由现金流率HOLXRIG
| Q4 25 | 20.5% | 30.8% | ||
| Q3 25 | 32.5% | 22.9% | ||
| Q2 25 | 32.3% | 10.5% | ||
| Q1 25 | 15.3% | -3.8% | ||
| Q4 24 | 16.9% | 18.6% | ||
| Q3 24 | 35.5% | 14.3% | ||
| Q2 24 | 38.1% | 5.7% | ||
| Q1 24 | 27.5% | -22.1% |
资本支出强度HOLXRIG
| Q4 25 | 1.4% | 2.7% | ||
| Q3 25 | 1.3% | 1.1% | ||
| Q2 25 | 1.3% | 2.4% | ||
| Q1 25 | 1.5% | 6.6% | ||
| Q4 24 | 1.6% | 3.0% | ||
| Q3 24 | 1.7% | 6.1% | ||
| Q2 24 | 2.0% | 9.8% | ||
| Q1 24 | 1.3% | 10.9% |
现金转化率HOLXRIG
| Q4 25 | 1.28× | 13.96× | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 1.76× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.94× | 29.43× | ||
| Q3 24 | 2.05× | — | ||
| Q2 24 | 2.09× | — | ||
| Q1 24 | 1.72× | -0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
RIG
| Ultra Deepwater Floaters | $433.0M | 42% |
| BR | $236.0M | 23% |
| Other Geographical | $211.0M | 20% |
| Harsh Environment Floaters | $163.0M | 16% |
